Nanophotosensitizers toward advanced photodynamic therapy of Cancer

Cancer Letters

Volumn 334, Issue 2, 2013, Pages 176-187

  Lim, Chang Keun ^a   Heo, Jeongyun ^a   Shin, Seunghoon ^b   Jeong, Keunsoo ^a,b   Seo, Young Hun ^a,c   Jang, Woo Dong ^c   Park, Chong Rae ^b   Park, Soo Young ^b   Kim, Sehoon ^a   Kwon, Ick Chan ^a  

^a Korea Institute of Science and Technology   (South Korea)

^b Seoul National University   (South Korea)

^c Yonsei University   (South Korea)

Author keywords

Nanomedicine; Nanotherapeutics; Photodynamic therapy; Photosensitizer

Indexed keywords

3 DIETHYLAMINOPROPYLISOTHIOCYANATE; CAMPTOTHECIN; CHITOSAN; CHLORIN E6; CHOLESTEROL; CYANINE DYE; DRUG CARRIER; GOLD NANOROD; GRAPHENE OXIDE; LIPOSOME; MACROGOL; MEROCYANINE; METHYLENE BLUE; NANOCARRIER; NANOPHOTOSENSITIZING AGENT; NANOROD; PEGAPTANIB; PHEOPHORBIDE A; PHOSPHOLIPID; PHOTOFRIN; PHOTOSENSITIZING AGENT; POLYGLACTIN; POLYGLYCOLIC ACID; POLYLACTIDE; POLYMER; PORPHYRIN DERIVATIVE; PYROPHEOPHORBIDE A; QUANTUM DOT; SILICON DIOXIDE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

BIOACCUMULATION; BIODEGRADABILITY; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CHEMICAL COMPOSITION; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG TARGETING; HUMAN; HYDROPHILICITY; HYDROPHOBICITY; LIPID BILAYER; MALIGNANT NEOPLASTIC DISEASE; MICELLE; MULTIDRUG RESISTANCE; NANOENCAPSULATION; NONHUMAN; PHOTODYNAMIC THERAPY; PHOTOSENSITIZATION; PHOTOTOXICITY; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SHORT SURVEY; TUMOR VASCULARIZATION;

EID: 84878240072     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2012.09.012     Document Type: Review

References (174)

1. Kronowitz S.J., Robb G.L. Radiation therapy and breast reconstruction: a critical review of the literature. Plast. Reconstr. Surg. 2009, 124:395-408.
2. Torok J., Wegner R.E., Burton S.A., Heron D.E. Stereotactic body radiation therapy for adrenal metastases: a retrospective review of a noninvasive therapeutic strategy. Future Oncol. 2011, 7:145-151.
3. Köhrmann K.U., Michel M.S., Gaa J., Marligghaus E., Alken P. High intensity focused ultrasound as noninvasive therapy for multilocal renal cell carcinoma: case study and review of the literature. J. Urol. 2002, 167:2397-2403.
4. Cordeiro1 E.R., Cathelineau X., Thüroff S., Marberger M., Crouzet S., de la Rosette J.J.M.C.H. High-intensity focused ultrasound (HIFU) for definitive treatment of prostate cancer. BJU Int. 2012, doi: 10.1111/j.1464-410X.2012.11262.x.
5. McClung E.C., Blumenthal P.D. Efficacy, safety, acceptability and affordability of cryotherapy: a review of current literature. Minerva Ginecol. 2012, 64:149-172.
6. Dolmans D.E.J.G.J., Fukumura D., Jain R.K. Photodynamic therapy for cancer. Nat. Rev. Cancer 2003, 3:380-387.
7. Allison R.R., Sibata A.H. Oncologic photodynamic therapy photosensitizers: a clinical review. Photodiagn. Photodyn. 2010, 7:61-75.
8. Yano S., Hirohara S., Obata M., Hagiya Y., Ogura S., Ikeda A., Kataoka H., Tanaka M., Joh T. Current states and future views in photodynamic therapy. J. Photochem. Photobiol. C 2011, 12:46-67.
9. Dougherty T.J., Gomer C.J., Henderson B.W., Jori G., Kessel D., Korbelik M., Moan J., Peng Q. Photodynamic therapy. J. Natl. Cancer Inst. 1998, 90:889-905.
10. Prasad P.N Introduction to Biophotonics 2003, Wiley, NY, 433-463.
11. Hasan T. Photodynamic Therapy: Basic Principles and Clinical Applications 1992, Mercel Dekker, New York.
12. Oleinick N.L., Morris R.L., Belichenko I. The role of apoptosis in response to photodynamic therapy: what, where, why, and how. Photochem. Photobiol. Sci. 2001, 1:1-21.
13. Derycke A.S.L., de Witte P.A.M. Liposomes for photodynamic therapy. Adv. Drug Deliv. Rev. 2004, 56:17-30.
14. Allison R.R., Mota H.C., Bagnato V.S., Sibata C.H. Bio-nanotechnology and photodynamic therapy-state of the art review. Photodiagn. Photodyn. 2008, 5:19-28.
15. Chatterjee D.K., Fong L.S., Zhang Y. Nanoparticles in photodynamic therapy: an emerging paradigm. Adv. Drug Deliv. Rev. 2008, 60:1627-1637.
16. Bechet D., Couleaud P., Frochot C., Viriot M.-L., Guillemin F., Barberi-Heyob M. Nanoparticles as vehicles for delivery of photodynamic therapy agents. Trends Biotechnol. 2008, 26:612-621.
17. Paszkoa E., Ehrhardtb C., Senge M.O., FTCD, Kelleherd D.P., Reynolds J.V. Nanodrug applications in photodynamic therapy. Photodiagn. Photodyn. 2011, 8:14-29.
18. Sharrna P., Brown S., Walter G., Santra S., Moudgil B. Nanoparticles for bioimaging. Adv. Colloid Interfac. 2006, 123:471-485.
19. Peng X.H., Qian X.M., Mao H., Wang A.Y., Chen Z., Nie S.M., Shin D.M. Targeted magnetic iron oxide nanoparticles for tumor imaging and therapy. Int. J. Nanomed. 2008, 3:311-321.
20. Ferrari M. Cancer nanotechnology: opportunities and challenges. Nat. Rev. Cancer 2005, 5:161-171.
21. Danhier F., Feron O., Preat V. To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. J. Control Release 2010, 148:135-146.
22. Danhier F., Ucakar B., Magotteaux N., Brewster M.E., Preat V. Active and passive tumor targeting of a novel poorly soluble cyclin dependent kinase inhibitor, JNJ-7706621. Int. J. Pharmaceut. 2010, 392:20-28.
23. Maeda H., Wu J., Sawa T., Matsumura Y., Hori K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J. Control Release 2000, 65:271-284.
24. Jin C.S., Zheng G. Liposomal nanostructures for photosensitizer delivery. Laser Surg. Med. 2011, 43:734-748.
25. Ali M.F.M. Topical delivery and photodynamic evaluation of a multivesicular liposomal Rose Bengal. Lasers Med. Sci. 2011, 26:267-275.
26. Fadel M., Kassab K. Evaluation of the photostability and photodynamic efficacy of Rose Bengal loaded in multivesicular liposomes. Trop. J. Pharm. Res. 2011, 10:289-297.
27. Garcia A.M., Alarcon E., Munoz M., Scaiano J.C., Edwards A.M., Lissi E. Photophysical behaviour and photodynamic activity of zinc phthalocyanines associated to liposomes. Photochem. Photobiol. Sci. 2011, 10:507-514.
28. Longo J.P.F., Leal S.C., Simioni A.R., Almeida-Santos M.D.M., Tedesco A.C., Azevedo R.B. Photodynamic therapy disinfection of carious tissue mediated by aluminum-chloride-phthalocyanine entrapped in cationic liposomes: an in vitro and clinical study. Lasers Med. Sci. 2012, 27:575-584.
29. Sreeram K.J., Narayan S., Abbineni G., Hayhurst A., Mao C.B. Architectonics of phage-liposome nanowebs as optimized photosensitizer vehicles for photodynamic cancer therapy. Mol. Cancer Ther. 2010, 9:2524-2535.
30. Tsai T., Yang Y.T., Wang T.H., Chien H.F., Chen C.T. Improved photodynamic inactivation of gram-positive bacteria using hematoporphyrin encapsulated in liposomes and micelles. Lasers Surg. Med. 2009, 41:316-322.
31. Yuan F., Dellian M., Fukumura D., Leunig M., Berk D.A., Torchilin V.P., Jain R.K. Vascular-permeability in a human tumor xenograft-molecular-size dependence and cutoff size. Cancer Res. 1995, 55:3752-3756.
32. Charrois G.J.R., Allen T.M. Rate of biodistribution of STEALTH liposomes to tumor and skin: influence of liposome diameter and implications for toxicity and therapeutic activity. BBS-Biomembranes 2003, 1609:102-108.
33. Lasic D.D., Martin F.J., Gabizon A., Huang S.K., Papahadjopoulos D. Sterically stabilized liposomes - a hypothesis on the molecular-origin of the extended circulation times. Biochim. Biophys. Acta 1991, 1070:187-192.
34. Needham D., Mcintosh T.J., Lasic D.D. Repulsive interactions and mechanical stability of polymer-grafted lipid-membranes. Biochim. Biophys. Acta 1992, 1108:40-48.
35. Francis G.E., Delgado C., Fisher D., Malik F., Agrawal A.K. Polyethylene glycol modification: relevance of improved methodology to tumour targeting. J. Drug Target. 1996, 3:321-340.
36. Bovis M.J., Woodhams J.H., Loizidou M., Scheglmann D., Bown S.G., MacRobert A.J. Improved in vivo delivery of m-THPC via pegylated liposomes for use in photodynamic therapy. J. Control Release 2012, 157:196-205.
37. van Nostrum C.F. Polymeric micelles to deliver photosensitizers for photodynamic therapy. Adv. Drug Deliv. Rev. 2004, 56:9-16.
38. Kataoka K., Harada A., Nagasaki Y. Block copolymer micelles for drug delivery: design, characterization and biological significance. Adv. Drug Deliv. Rev. 2001, 47:113-131.
39. Bugaj A.M. Targeted photodynamic therapy-a promising strategy of tumor treatment. Photochem. Photobiol. Sci. 2011, 10:1097-1109.
40. Panyam J., Zhou W.Z., Prabha S., Sahoo S.K., Labhasetwar V. Rapid endo-lysosomal escape of poly(d,l-lactide-co-glycolide) nanoparticles: implications for drug and gene delivery. Faseb J. 2002, 16:1217-1225.
41. Konan Y.N., Cerny R., Favet J., Berton M., Gurny R., Allemann E. Preparation and characterization of sterile sub-200 nm meso-tetra(4-hydroxylphenyl)porphyrin-loaded nanoparticles for photodynamic therapy. Eur. J. Pharm. Biopharm. 2003, 55:115-124.
42. Konan Y.N., Berton M., Gurny R., Allemann E. Enhanced photodynamic activity of meso-tetra(4-hydroxyphenyl)porphyrin by incorporation into sub-200 nm nanoparticles. Eur. J. Pharm. Sci. 2003, 18:241-249.
43. Koo Y.E.L., Fan W., Hah H., Xu H., Orringer D., Ross B., Rehemtulla A., Philbert M.A., Kopelman R. Photonic explorers based on multifunctional nanoplatforms for biosensing and photodynamic therapy. Appl. Optics 2007, 46:1924-1930.
44. Kopelman R., Koo Y.E.L., Philbert M., Moffat B.A., Reddy G.R., McConville P., Hall D.E., Chenevert T.L., Bhojani M.S., Buck S.M., Rehemtulla A., Ross B.D. Multifunctional nanoparticle platforms for in vivo MRI enhancement and photodynamic therapy of a rat brain cancer. J. Magn. Magn. Mater. 2005, 293:404-410.
45. Moffat B.A., Reddy G.R., McConville P., Hall D.E., Chenevert T.L., Kopelman R.R., Philbert M., Weissleder R., Rehemtulla A., Ross B.D. A novel polyacrylamide magnetic nanoparticle contrast agent for molecular imaging using MRI. Mol. Imaging 2003, 2:324-332.
46. Schmitt F., Lagopoulos L., Kauper P., Rossi N., Busso N., Barge J., Wagnieres G., Laue C., Wandrey C., Juillerat-Jeanneret L. Chitosan-based nanogels for selective delivery of photosensitizers to macrophages and improved retention in and therapy of articular joints. J. Control. Release 2010, 144:242-250.
47. Li F., Bae B.C., Na K. Acetylated hyaluronic acid/photosensitizer conjugate for the preparation of nanogels with controllable phototoxicity: synthesis, characterization, autophotoquenching properties, and in vitro phototoxicity against HeLa Cells. Bioconjugate Chem. 2010, 21:1312-1320.
48. Roy I., Ohulchanskyy T.Y., Pudavar H.E., Bergey E.J., Oseroff A.R., Morgan J., Dougherty T.J., Prasad P.N. Ceramic-based nanoparticles entrapping water-insoluble photosensitizing anticancer drugs: a novel drug-carrier system for photodynamic therapy. J. Am. Chem. Soc. 2003, 125:7860-7865.
49. Sharman W.M., van Lier J.E., Allen C.M. Targeted photodynamic therapy via receptor mediated delivery systems. Adv. Drug Deliv. Rev. 2004, 56:53-76.
50. Zhou A., Wei Y., Wu B., Chen Q., Xing D. Pyrophenophorbide A and c(RGDyk) comodified chitosan-wrapped upconversion nanoparticle for targeted near-infrared photodynamic therapy. Mol. Pharm. 2012, 9:1580-1589.
51. ichikawa K., Hikita T., Maeda N., Yonezawa S., Takeuchi Y., Asai T., Namba Y., Oku N. Antiangiogenic photodynamic therapy (PDT) by using long-circulating liposomes modified with peptide specific to angiogenic vessels. Biochim. Biophys. Acta 2005, 1669:69-74.
52. Rahmanzadeh R., Rai P., Celli J.P., Rizvi I., Baron-Lühr B., Gerdes J., Hasan T. Ki-67 as a molecular target for therapy in an in vitro 3D model for ovarian cancer. Cancer Res. 2010, 70:9234-9242.
53. Yanga S.-J., Lina F.-H., Tsaia H.-M., Lina C.-F., China H.-C., Wonga J.-M., Shieha M.-J. Alginate-folic acid-modified chitosan nanoparticles for photodynamic detection of intestinal neoplasms. Biomaterials 2011, 32:2174-2182.
54. Huang P., Xu C., Lin J., Wang C., Wang X., Zhang C., Zhou X., Guo S., Cui D. Folic acid-conjugated graphene oxide loaded with photosensitizers for targeting photodynamic therapy. Theranostics 2011, 1:240-250.
55. Bae B., Na K. Self-quenching polysaccharide-based nanogels of pullulan/folate-photosensitizer conjugates for photodynamic therapy. Biomaterials 2010, 31:6325-6335.
56. Yoon H.Y., Koo H., Choi K.Y., Lee S.J., Kim K., Kwon I.C., Leary J.F., Park K., Yuk S.H., Park J.H., Choi K. Tumor-targeting hyaluronic acid nanoparticles for photodynamic imaging and therapy. Biomaterials 2012, 33:3980-3989.
57. Gary-Bobo M., Brevet D., Benkirane-Jessel N., Raehmb L., Maillard P., Garcia M., Durand J.-O. Hyaluronic acid-functionalized mesoporous silica nanoparticles for efficient photodynamic therapy of cancer cells. Photodiagn. Photodyn. 2012, 9:256-260.
58. 6 enhances its photosensitizing activity. J. Biol. Chem. 1997, 272:20328-20331.
59. Reddy G.R., Bhojani M.S., MaConville P., Moody J., Moffat B.A., Hall D.E., Kim G., Koo Y.L., Woolliscroft M.J., Sugai J.V., Johnson T.D., Philbert M.A., Kopelman R., Rehemtulla A., Ross B.D. Vascular targeted nanoparticles for imaging and treatment of brain tumors. Clin. Cancer Res. 2006, 12:6677-6686.
60. Hah H.J., Kim G., Lee Y.-E.K., Orringer D.A., Sagher O., Philbert M.A., Kopelman R. Methylene blue-conjugated hydrogel nanoparticles and tumor-cell targeted photodynamic therapy. Macromol. Biosci. 2011, 11:90-99.
61. Wang S., Kim G., Lee Y.-E.K., Hah H.J., Ethirajan M., Pandey R.K., Kopelman R. Multifunctional biodegradable polyacrylamide nanocarriers for cancer theranostics-a " see and treat" strategy. ACS Nano 2012, 6:6843-6851.
62. Gary-Bobo M., Mir Y., Rouxel C., Brevet D., Basile I., Maynadier M., Vaillant O., Mongin O., Blanchard-Desce M., Morère A., Garcia M., Durand J.-O., Raehm L. Angew. Chem. 2011, 123:11627-11631.
63. Gary-Bobo M., Mir Y., Rouxel C., Brevet D., Hocine O., Maynadier M., Gallud A., Silva A.D., Mongin O., Blanchard-Desce M., Richeter S., Loockd B., Maillardd P., Morère A., Garcia M., Raehm L., Durand J.-O. Multifunctionalized mesoporous silica nanoparticles for the in vitro treatment of retinoblastoma: drug delivery, one and two-photon photodynamic therapy. Int. J. Pharm. 2012, 432:99-104.
64. Obaid G., Chambrier I., Cook M.J., Russell D.A. Targeting of oncofetal Thomsen-Friedenreich disaccharide Jacalin-PEG phthalocyanine gold nanoparticle for photodynamic cancer therapy. Angew. Chem. 2012, 124:1-6.
65. Yin M., Li Z., Liu Z., Ren J., Yang X., Qu X. Photosensitizer-incorporated G-quadruplex DNA-functionalized magnetofluorescent nanoparticles for targeted magnetic resonance/fluorescence multimodal imaging and subsequent photodynamic therapy of cancer. Chem. Commun. 2012, 10.1039/c2cc32129g.
66. Weiss A., van den Bergh H., Griffioen A.W., Nowak-Slivinska P. Angiogenesis inhibition for the improvement of photodynamic therapy: the revival of a promising idea. Biochim. Biophys. Acta Rev. Canc. 1826, 2012:57-70.
67. Zuluaga M., Mailbos C., Robinson G., Shima D.T., Gurny R., Lange N. Synergies of VEGF inhibition and photodynamic therapy in the treatment of age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 2007, 48:1767-1772.
68. Kamrava M., Bernstein M.B., Camphausen K., Hodge J.W. Combining radiation, immunotherapy, and antiangiogenesis agents in the management of cancer: Three Musketeers or just another quixotic combination?. Mol. Biosyst. 2009, 5:1262-1270.
69. Abu-Yousif A.O., Moor A.C.E., Zheng X., Savellano M.D., Yu W., Selbo K., Hasan T. Epidermal growth factor receptor-targeted photosensitizer selectively inhibits EFGR signaling and induces targeted phototoxicity in ovarian cancer cells. Cancer Lett. 2012, 321:120-127.
70. Kim J.H., Bae S.M., Na M., Shin H, Yang Y.J., Min K.H., Choi K.Y., Kim K., R.W.Park, Kwon I.C., Lee B.H., Hoffman A.S., Kim I.S. Facilitated intracellular delivery of peptide-guided nanoparticles in tumor tissues. J. Control. Release 2012, 157:493-499.
71. Tirand L., Frochot C., Vanderesse R., Thomas N., Trinquet E., Pinel S., Viriot M., Guillemin F., Barberi-Heyob M. A peptide competing with VEGF165 binding on neuropilin-1 mediates targeting of a chlorin-type photosensitizer and potentiates its photodynamic activity in human endothelial cells. J. Control. Release 2006, 111:153-164.
72. Thomas N., Bechet D., Becuwe P., Tirand L., Vanderesse R., Frochot C., Guillemin F., Barberi-Heyob M. Peptide-conjugated chlorin-type photosensitizer binds neuropilin-1 in vitro and in vivo. J. Photochem. Photobiol. B: Biol. 2009, 96:101-108.
73. Bulluos A.J., Alonso C.M.A., Boyle R.W. Photosensitizer-antibody conjugates for photodynamic therapy. Photochem. Photobiol. Sci. 2011, 10:721-750.
74. Kwitniewski M., Juzeniene A., Glosnicka R., Moan J. Immunotherapy: a way to improve the therapeutic outcome of photodynamic therapy?. Photochem. Photobiol. Sci. 2008, 7:1011-1017.
75. Herbst R.S., Shin D.M. Monoclonal antibodies to target epidermal growth factor receptor-positive tumors: a new paradigm for cancer therapy. Cancer 2002, 94:1593-1611.
76. Chaleix V., Sol V., Huang Y., Guilloton M., Granet R., Biais J.C., Krausz P. RGD porphyrin conjugates: synthesis and potential application in photodynamic therapy. Eur. J. Org. Chem. 2003, 8:1486-1493.
77. Frochot C., Stasio B.D., Vanderesse R., Belgy M., Dodeller M., Gukllemin F., Viriot M., Barberi-Heyob M. Interest of RGD-containing linear or cyclic peptide targeted tetraphenylchlorin as novel photosensitizers for selective photodynamic activity. Bioorg. Chem. 2007, 35:205-220.
78. Conway C.L., Walker I., Bell A., Roberts D.J.H., Brown S.B., Vernon D.I. In vivo and in vitro characterization of a protoporphyrin IX-cyclic RGD peptide conjugate for use in photodynamic therapy. Photochem. Photobiol. Sci. 2008, 7:290-298.
79. Dube D.H., Bertozzi C.R. Glycans in cancer and inflammation-potential for therapeutics and diagnostics. Nat. Rev. Drug Discov. 2005, 4:477-488.
80. Wagstaff K.M., Jans D.A. Nuclear drug delivery to target tumor cells. Eur. J. Pharm. 2009, 625:174-180.
81. Moan J. On the diffusion length of singlet oxygen in cells and tissues. J. Photochem. Photobiol. B 1990, 6:343-344.
82. Bisland S.K., Singh D., Gariépy J. Potentiation of chlorin e6 photodynamic activity in vitro with peptide-based intracellular vehicles. Bioconjugate Chem. 1999, 10:982-992.
83. Christian S., Pilch J., Akeman M.E., Porkka K., Laakkonen P., Ruoslahti E. Nucleolin expressed at the cell surface is a marker of endothelial cells in angiogenic blood vessels. J. Cell Biol. 2003, 163:871-878.
84. Bugaj A.M. Targeted photodynamic therapy-a promising strategy of tumor treatment. Photochem. Photobiol. Sci. 2011, 10:1097-1109.
85. Ng E.W.M., Shima D.T., Calias P., Cunningham E.T., Guyer D.R., Adamis A.P. Pegaptanib, A targeted anti-VEGF aptamer for ocular vascular disease. Nat. Rev. Drug Discov. 2006, 5:123-132.
86. Reyes-Reyes E.M., Teng Y., Bates P.J. A new paradigm for aptamer therapeutic AS1411 action: uptake by macropinocytosis and stimulation by a nucleolin-dependent mechanism. Cancer Res. 2010, 70:8617-8629.
87. Shieh Y., Yang S., Wei M., Shieh M. Aptamer-based tumor-targeted drug delivery for photodynamic therapy. ACS Nano 2010, 4:1433-1442.
88. Jayasena S.D. Aptamers: an emerging class of molecules that rival antibodies in diagnostics. Clin. Chem. 1999, 45:1628-1650.
89. Stella B., Arpicco S., Peracchia M.T., Desmaële D., Hoebeke J., Renoir M., D'Angelo J., Cattel L., Couvreur P. Design of folic acid-conjugated nanoparticles for drug targeting. J. Pharm. Sci. 2000, 89:1452-1464.
90. Lovell J.F., Liu T.W.B., Chen J., Zheng G. Activatable photosensitizers for imaging and therapy. Chem. Rev. 2010, 110:2839-2857.
91. Verhille M., Couleaud P., Vanderesse R., Brault D., Barberi-Heyob M., Frochot C. Modulation of photosensitization processes for an improved targeted photodynamic therapy. Curr. Med. Chem. 2010, 17:3925-3943.
92. Bonneau R., Pottier R., Bagno O., Joussot-Dubien J. PH dependence of singlet oxygen production in aqueous solutions using thiazine dyes as photosensitizers. Photochem. Photobiol. 1975, 21:159-163.
93. Pottier R., Bonneau R., Joussot-Dubien J. PH dependence of singlet oxygen production in aqueous solutions using toluidine blue as a photosensitizer. Photochem. Photobiol. 1975, 22:59-61.
94. Vakrat-Haglili Y., Weiner L., Brumfeld V., Brandis A., Salomon Y., McLlroy B., Wilson B.C., Pawlak A., Rozanowska M., Sarna T., Scherz A. The microenvironment effect on the generation of reactive oxygen species by Pd-bacteriopheophorbide. J. Am. Chem. Soc. 2005, 127:6487-6497.
95. Spiller W., Kliesch H., Wohrle D., Hackbarth S., Roder B., Schnurpfeil G. Singlet oxygen quantum yields of different photosensitizers in polar solvents and micellar solutions. J. Porphyrins Phthalocyanin. 1998, 2:145-158.
96. Arnbjerg J., Johnsen M., Nielsen C.B., Jorgensen M., Ogilby P.R. Effect of sensitizer protonation on singlet oxygen production in aqueous and nonaqueous media. J. Phys. Chem. A 2007, 111:4573-4583.
97. McDonnell S.O., Hall M.J., Allen L.T., Byrne A., Gallagher W.M., O'Shea D.F. Supramolecular photonic therapeutic agents. J. Am. Chem. Soc. 2005, 127:16360-16361.
98. Urano Y., Asanuma D., Hama Y., Koyama Y., Barrett T., Kamiya M., Nagano T., Watanabe T., Hasegawa A., Choyke P.L., Kobayashi H. Selective molecular imaging of viable cancer cells with pH-activatable fluorescence probes. Nat. Med. 2009, 15:104-109.
99. Jiang X.J., Lo P.C., Tsang Y.M., Yeung S.L., Fong W.P., Ng D.K. Phthalocyanine-polyamine conjugates as pH-controlled photosensitizers for photodynamic therapy. Chem. Eur. J. 2010, 16:4777-4783.
100. Zhu X.C., Lu W.T., Zhang Y.Z., Reed A., Newton B., Fan Z., Yu H.T., Ray P.C., Gao R.M. Imidazole-modified porphyrin as a pH-responsive sensitizer for cancer photodynamic therapy. Chem. Commun. 2011, 47:10311-10313.
101. Shieh M.J., Peng C.L., Chiang W.L., Wang C.H., Hsu C.Y., Wang S.J., Lai P.S. Reduced skin photosensitivity with meta-tetra(hydroxyphenyl)chlorin-loaded micelles based on a poly(2-ethyl-2-oxazoline)-b-poly(d,l-lactide) diblock copolymer in vivo. Mol. Pharmaceutics 2010, 7:1244-1253.
102. Park S.Y., Baik H.J., Oh Y.T., Oh K.T., Youn Y.S., Lee E.S. A smart polysaccharide/drug conjugate for photodynamic therapy. Angew. Chem. Int. Edit. 2011, 50:1644-1647.
103. Sivaguru J., Solomon M.R., Poon T., Jockusch S., Bosio S.G., Adam W., Turro N.J. The reaction of singlet oxygen with enecarbamates: a mechanistic playground for investigating chemoselectivity, stereoselectivity, and vibratioselectivity of photooxidations. Acc. Chem. Res. 2008, 41:387-400.
104. Couleaud P., Morosini V., Frochot C., Richeter S., Raehm L., Durand J.O. Silica-based nanoparticles for photodynamic therapy applications. Nanoscale 2010, 2:1083-1095.
105. Kim S., Pudavar H.E., Bonoiu A., Prasad P.N. Aggregation-enhanced fluorescence in organically modified silica nanoparticles: a novel approach toward high-signal-output nanoprobes for two-photon fluorescence bioimaging. Adv. Mater. 2007, 19:3791-3795.
106. Dash S., Mishra S., Patel S., Mishra B.K. Organically modified silica: synthesis and applications due to its surface interaction with organic molecules. Adv. Colloid. Int. Sci. 2008, 140:77-94.
107. Jones C.F., Grainger D.W. In vitro assessments of nanomaterial toxicity. Adv. Drug Deliv. Rev. 2009, 61:438-456.
108. 2 generation. Nanotechnology 2010, 21:115102.
109. Szekeres M., Dekany I., de K.A. Adsorption of dodecyl pyridinium chloride on monodisperse porous silica. Colloids Surf. A 1998, 141:327-336.
110. Hartley P.G., Larson I., Scales P.J. Electrokinetic and direct force measurements between silica and mica surfaces in dilute electrolyte, solutions. Langmuir 1997, 13:2207-2214.
111. Li W., Lu W., Fan Z., Zhu X., Reed A., Newton B., Zhang Y., Courtney S., Tiyyagura P.T., Ratcliff R.R., Li S., Butler E., Yu H., Ray P.C., Gao R. Enhanced photodynamic selectivity of nano-silica-attached porphyrins against breast cancer cells. J. Mater. Chem. 2012, 22:12701-12708.
112. Marras S.A.E., Kramer F.R., Tyagi S. Efficiencies of fluorescence resonance energy transfer and contact-mediated quenching in oligonucleotide probes. Nucleic Acids Res. 2002, 30. e122/121-e122/128.
113. Choi Y., Weissleder R., Tung C.-H. Protease-mediated phototoxicity of a polylysine-chlorine6 conjugate. ChemMedChem 2006, 1:698-701.
114. Choi Y., Weissleder R., Tung C.-H. Selective antitumor effect of novel protease-mediated photodynamic agent. Cancer Res. 2006, 66:7225-7229.
115. Gabriel D., Campo M.A., Gurny R., Lange N. Tailoring protease-sensitive photodynamic agents to specific disease-associated enzymes. Bioconjugate Chem. 2007, 18:1070-1077.
116. Zheng G., Chen J., Stefflova K., Jarvi M., Li H., Wilson B.C. Photodynamic molecular beacon as an activatable photosensitizer based on protease-controlled singlet oxygen quenching and activation. Proc. Natl. Acad. Sci. USA 2007, 104:8989-8994.
117. Chen J., Stefflova K., Niedre M.J., Wilson B.C., Chance B., Glickson J.D., Zheng G. Protease-triggered photosensitizing beacon based on singlet oxygen quenching and activation. J. Am. Chem. Soc. 2004, 126:11450-11451.
118. Lo P.C., Chen J., Stefflova K., Warren M.S., Navab R., Bandarchi B., Mullins S., Tsao M., Cheng J.D., Zheng G. Photodynamic molecular beacon triggered by fibroblast activation protein on cancer-associated fibroblasts for diagnosis and treatment of epithelial cancers. J. Med. Chem. 2009, 52:358-368.
119. Jang B., Choi Y. Photosensitizer-conjugated gold nanorods for enzyme-activatable fluorescence imaging and photodynamic therapy. Theranostics 2012, 2:190-197.
120. Bae B.C., Na K. Self-quenching polysaccharide-based nanogels of pullulan/folate-photosensitizer conjugates for photodynamic therapy. Biomaterials 2010, 31:6325-6335.
121. Park W., Park S.J., Na K. The controlled photoactivity of nanoparticles derived from ionic interactions between a water soluble polymeric photosensitizer and polysaccharide quencher. Biomaterials 2011, 32:8261-8270.
122. Weishaupt K.R., Gomer C.J., Dougherty T.J. Identification of singlet oxygen as the cytotoxic agent in photo-inactivation of a murine tumor. Cancer Res. 1976, 36:2326-2329.
123. Dougherty T.J. Photosensitizers: therapy and detection of malignant tumors. Photochem. Photobiol. 1987, 45:879-889.
124. El-Sayed M.A. The triplet state: its radiative and nonradiative properties. Acc. Chem. Res. 1968, 1:8-16.
125. McGlynn S.P., Azumi T., Kinoshita M. Molecular Spectroscopy of the Triplet State 1969, Prentice Hall, Englewood Cliffs, NJ.
126. DeRosa M.C., Crutchey R.J. Photosensitized singlet oxygen and its applications. Coord. Chem. Rev. 2002, 223-234:351-371.
127. Luksiene Z. Photodynamic therapy: mechanism of action and ways to improve the efficiency of treatment. Medicina 2003, 39:1137-1150.
128. Birks J.B. Photophysics of Aromatic Molecules 1970, Wiley, London.
129. Turro N.J. Modern Molecular Photochemistry 1978, Benjamin, MenloPark.
130. Valeur B. Molecular Fluorescence: Principles and Applications 2001, Wiley-VCH Verlag GmbH, Weinheim.
131. Gorman A., Killoran J., O'Shea C., Kenna T., Gallagher W.M., O'Shea D.F. In vitro demonstration of the heavy-atom effect for photodynamic therapy. J. Am. Chem. Soc. 2004, 126:10619-10631.
132. Yogo T., Urano Y., Ishitsuka Y., Maniwa F., Nagano T. Highly efficient and photostable photosensitizer based on BODIPY chromophore. J. Am. Chem. Soc. 2005, 127:12162-12163.
133. Arunkumar E., Sudeep P.K., Kamat P.V., Noll B.C., Smith B.D. Singlet oxygen generation using iodinated squaraine and squaraine-rotaxane dyes. New J. Chem. 2007, 31:677-683.
134. Pereira M.M., Monteiro C.J.P., Simões A.V.C., Pinto S.M.A., Arnaut L.G., Sá G.F.F., Silva E.F.F., Rocha L.B., Simões S., Formosinho S.J. Synthesis and photophysical properties of amphiphilic halogenated bacteriochlorins: new opportunities for photodynamic therapy of cancer. J. Porphyrins Phthalocyanines 2009, 13:567-573.
135. Serra A., Pineiro M., Santos C.I., Rocha Gonsalves A.M.D., Abrantes M., Laranjo M., Botelho M.F. In vitro photodynamic activity of 5,15-bis(3-hydroxyphenyl)porphyrin and its halogenated derivatives against cancer cells. Photochem. Photobiol. 2010, 86:206-212.
136. Quartarolo A.D., Chiodo S.G., Russo N. A theoretical study of brominated porphycenes: electronic spectra and intersystem spin-orbit coupling. J. Chem. Theory Comput. 2010, 6:3176-3189.
137. Ohulchanskyy T.Y., Donnelly D.J., Detty M.R., Prasad P.N. Heteroatom substitution induced changes in excited-state photophysics and singlet oxygen generation in chalcogenoxanthylium dyes: effect of sulfur and selenium substitutions. J. Phys. Chem. B 2004, 108:8668-8672.
138. Rubio N., Prat F., Bou N., Borrell J.I., Teixido J., Villanueva A., Juarranz A., Canete M., Stockert J.C., Nonell S. A comparison between the photophysical and photosensitizing properties of tetraphenyl porphycenes and porphyrins. New J. Chem. 2005, 29:378-384.
139. Vakrat-Haglili Y., Weiner L., Brumfeld V., Brandis A., Salomon Y., Mcllroy B., Wilson B.C., Pawlak A., Rozanowska M., Sarna T., Scherz A. The microenvironment effect on the generation of reactive oxygen species by Pd-bacteriopheophorbide. J. Am. Chem. Soc. 2005, 127:6487-6497.
140. Lanzo I., Russo N., Sicilia E. First-principle time-dependent study of magnesium-containing porphyrin-like compounds potentially useful for their application in photodynamic therapy. J. Phys. Chem. B 2008, 112:4123-4130.
141. Obata M., Hirohara S., Tanaka R., Kinoshita I., Ohkubo K., Fukuzumi S., Tanihara M., Yano S. In vitro heavy-atom effect of palladium(II) and platinum(II) complexes of pyrrolidine-fused chlorin in photodynamic therapy. J. Med. Chem. 2009, 52:2747-2753.
142. Kim S., Ohulchanskyy T.Y., Bharali D., Chen Y., Pandey R.K., Prasad P.N. Organically modified silica nanoparticles with intraparticle heavy-atom effect on the encapsulated photosensitizer for enhanced efficacy of photodynamic therapy. J. Phys. Chem. C 2009, 113:12641-12644.
143. Lim C.-K., Shin J., Lee Y.-D., Kim J., Park H., Kwon I.C., Kim S. Heavy-atomic construction of photosensitizer nanoparticles for enhanced photodynamic therapy of cancer. Small 2011, 7:112-118.
144. Lim C.-K., Shin J., Kwon I.C., Jeong S.Y., Kim S. Iodinated photosensitizing chitosan: self-assembly into tumor-homing nanoparticles with enhanced singlet oxygen generation. Bioconjugate Chem. 2012, 23:1022-1028.
145. Torchilin V.P. Micellar nanocarriers: pharmaceutical perspectives. Pharm. Res. 2007, 24:1-16.
146. MacDonald I.J., Dougherty T.J. Basic principles of photodynamic therapy. J. Porph. Pthalocyn. 2001, 5:105-129.
147. Lakowicz J.R. Principles of Fluorescence Spectroscopy, second ed. 1999, Kluwer Academic/Plenum Publishers, New York.
148. Samia A.C.S., Dayal S., Burda C. Quantum dot-based energy transfer: perspectives and potential for applications in photodynamic therapy. Photochem. Photobiol. 2006, 82:617-625.
149. Medintz I.L., Mattoussi H. Quantum dot-based resonance energy transfer and its growing application in biology. Phys. Chem. Chem. Phys. 2009, 11:17-45.
150. Dayal S., Burda C. Surface effects on quantum dot-based energy transfer. J. Am. Chem. Soc. 2007, 129:7977-7981.
151. Tsay J.M., Trzoss M., Shi L., Kong X., Selke M., Jung M.E., Weiss S. Singlet oxygen production by peptide-coated quantum dot-photosensitizer conjugates. J. Am. Chem. Soc. 2007, 129:6865-6871.
152. Idowu M., Chen J.-Y., Nyokong T. Photoinduced energy transfer between water-soluble CdTe quantum dots and aluminium tetrasulfonated phthalocyanine. New J. Chem. 2008, 32:290-296.
153. Alexiades-Armenakas M. Laser-mediated photodynamic theraphy. Clin. Dermatol. 2006, 24:16-25.
154. Chen W., Zhang J. Using nanoparticles to enable simultaneous radiation and photodynamic therapies for cancer treatment. J. Nanosci. Nanotechnol. 2006, 6:1159-1166.
155. Juzenas P., Chen W., Sun Y.-P., Coelho M.A.N., Generalov R., Generalova N., Christensen I.L. Quantum dots and nanoparticles for photodynamic and radiation therapies of cancer. Eur. Radiol. 2003, 13:195-208.
156. Liu Y., Chen W., Wang S., Joly A.G. Investigation of water-soluble X-ray luminescence nanoparticles for photodynamic activation. Appl. Phys. Lett. 2008, 92:043901.
157. Zhang P., Steelant W., Kumar M., Scholfield M. Versatile photosensitizers for photodynamic therapy at infrared excitation. J. Am. Chem. Soc. 2007, 129:4526-4527.
158. Chatterjee D.K., Yong Z. Upconverting nanoparticles as nanotransducers for photodynamic therapy in cancer cells. Nanomedicine 2008, 3:73-82.
159. Wang C., Tao H., Cheng L., Liu Z. Near-infrared light induced in vivo photodynamic therapy of cancer based on upconversion nanoparticles. Biomaterials 2011, 32:6145-6154.
160. Lim M.E., Lee Y., Zhang Y., Chu J.J.H. Photodynamic inactivation of viruses using upconversion nanoparticles. Biomaterials 2012, 33:1912-1920.
161. Cui S., Chen H., Zhu H., Tian J., Chi X., Qian Z., Achilefu S., Gu Y. Amphiphilic chitosan modified upconversion nanoparticles for in vivo photodynamic therapy induced by near-infrared light. J. Mater. Chem. 2012, 22:4861-4873.
162. Zhou A., Wei Y., Wu B., Chen Q., Xing D. Pyropheophorbide a and c(RGDyK) comodified chitosan-wrapped upconversion nanoparticle for targeted near-infrared photodynamic therapy. Mol. Pharm. 2012, 9:1580-1589.
163. Fisher W.G., Partridge W.P., Dees C., Wachter E.A. Simultaneous two-photon activation of type-I photodynamic therapy agents. Photochem. Photobiol. 1997, 66:141-155.
164. Karotki A., Kruk M., Drobizhev M., Rebane A., Nickel E., Spangler C.W. Efficient singlet oxygen generation upon two-photon excitation of new porphyrin with enhanced nonlinear absorption. IEEE J. Sel. Top. Quantum Electron. 2001, 7:971-975.
165. Frederiksen P.K., Jørgensen M., Ogilby P.R. Two-photon photosensitized production of singlet oxygen. J. Am. Chem. Soc. 2001, 123:1215-1221.
166. Karotki A., Drobizhev M., Kruk M., Spangler C.W., Nickel E., Mamardashvili N., Rebane A. Enhancement of two-photon absorption in tetrapyrrolic compounds. J. Opt. Soc. Am. B 2003, 20:321-332.
167. Frederiksen P.K., Mcllroy S.P., Nielsen C.B., Nikolajsen L., Skovsen E., Jørgensen M., Mikkelsen K.V., Ogilby P.R. Two-photon photosensitized production of singlet oxygen in water. J. Am. Chem. Soc. 2005, 127:255-269.
168. Mcllroy S.P., Clo E., Nikolajsen L., Frederiksen P.K., Nielsen C.B., Mikkelsen K.V., Gothelf K.V., Ogilby P.R. Two-photon photosensitized production of singlet oxygen: sensitizers with phenylene-ethynylene-based chromophores. J. Org. Chem. 2005, 70:1134-1137.
169. Kim S., Ohulchanskyy T.Y., Pudavar H.E., Pandey R.K., Prasad P.N. Organically modified silica nanoparticles co-encapsulating photosensitizing drug and aggregation-enhanced two-photon absorbing fluorescent dye aggregates for two-photon photodynamic therapy. J. Am. Chem. Soc. 2007, 129:2669-2675.
170. Lebret V., Raehm L., Durand J.-O., Smaïhi M., Gérardin C., Nerambourg N., Werts M.H.V., Blanchard-Desce M. Synthesis and characterization of fluorescently doped mesoporous nanoparticles for two-photon excitation. Chem. Mater. 2008, 20:2174-2183.
171. Chen C.-Y., Tian Y., Cheng Y.-J., Young A.C., Ka J.-W., Jen A.K.-Y. Two-photon absorbing block copolymer as a nanocarrier for porphyrin: energy transfer and singlet oxygen generation in micellar aqueous solution. J. Am. Chem. Soc. 2007, 129:7220-7221.
172. Schladt T.D., Schneider K., Shukoor M.I., Natalio F., Bauer H., Tahir M.N., Weber S., Schreiber L.M., Schröder H.C., Müller W.E.G., Treme W. Highly soluble multifunctional MnO nanoparticles for simultaneous optical and MRI imaging and cancer treatment using photodynamic therapy. J. Mater. Chem. 2010, 20:8297-8304.
173. He J., Chen J.-Y., Wang P., Wang P.-N., Guo J., Yang W.-L., Wang C.-C., Peng Q. Poly(N-isopropylacrylamide)-coated thermo-responsive nanoparticles for controlled delivery of sulfonated Zn-phthalocyanine in Chinese hamster ovary cells in vitro and zebra fish in vivo. Nanotechnology 2007, 18:415101.
174. Celli J.P., Spring B.Q., Rizvi I., Evans C.L., Samkoe K.S., Verma S., Pogue B.W., Hasan T. Imaging and photodynamic therapy: mechanisms, monitoring, and optimization. Chem. Rev. 2010, 110:2795-2838.